The Federal Government has intensified the fight against antimicrobial resistance, which is estimated to lead to a global US$ 1 trillion additional healthcare costs by 2050, and US$ 1 trillion to US$ 3.4 trillion gross domestic product (GDP) losses per year by 2030, with the launch of the